LL-37
Also known as: Cathelicidin · antimicrobial peptide · CAP-18 fragment
A human cathelicidin antimicrobial peptide studied for host defence, wound healing and modulation of inflammation.
LL-37 is the only cathelicidin-family antimicrobial peptide found in humans — a 37-residue peptide (beginning with two leucines, hence the name) that is part of the innate immune system’s first line of defence.
Research interest spans direct antimicrobial activity against bacteria, immune signalling, and roles in wound healing and angiogenesis. It sits in the immune-defence and tissue-repair research categories.
Handled strictly for research purposes only.
ON THIS SITE
RELATED TERMS
Immunomodulation
Adjusting the immune system up or down toward balance — the research theme behind thymic and defence peptides.
Angiogenesis
The formation of new blood vessels from existing ones — central to how tissue-repair peptides are studied.
Inflammation / Anti-inflammatory
The body’s protective response to injury; calming excess inflammation is a target of gut- and repair-peptide research.
Amino-Acid Sequence
The specific order of amino-acid residues in a peptide — its "primary structure" — which dictates shape and activity.
Educational content, not medical advice. All products supplied for research purposes only — not for human consumption.